Melatonin-induced glycosaminoglycans augmentation in myocardium remote to infarction

Journal of Physiology and Pharmacology

Volumn 64, Issue 6, 2013, Pages

  Drobnik, J ^a   Tosik, D ^a   Piera, L ^a   Szczepanowska, A ^a   Olczak, S ^a   Zielinska, A ^a   Liberski, P P ^a   Ciosek, J ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Cell culture; Collagen; Connective tissue; Glycosaminoglycans; Luzindole; Melatonin; Myocardial infarction; Pineal gland; Repair

Indexed keywords

COLLAGEN; GLYCOSAMINOGLYCAN; INDOLEAMINE; LUZINDOLE; MELATONIN; MELATONIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; FIBROBLAST; HEART INFARCTION; MALE; NONHUMAN; RAT; SPECTROPHOTOMETRY;

EID: 84891701499     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Erlebacher JA, Weiss JL, Weisfeldt ML, Bulkley BH. Early dilation of infarcted segment in acute transmural myocardial infarction: role of infarct expansion in acute left ventricular enlargement. J Am Coll Cardiol 1984; 4: 201-208.
2. Laeremans H, Hackeng TM, van Zandvoort MA, et al. Blocking of frizzled signaling with the homologous peptide fragment of wnt3a/wnt5a reduces infarct expansion and prevents the development of heart failure after myocardial infarction. Circulation 2011; 124: 1626-1635.
3. Jugdutt BI. Remodeling of myocardium and potential targets in the collagen degradation and synthesis pathways. Curr Drug Targets Cardiovasc Haematol Dis 2003; 3: 1-30.
4. Tyagi SC, Campbell SE, Reddy HK, Tjahia E, Voelker DJ. Matrix metalloproteinase activity expression in infarcted, noninfarcted and dilated cardiomyopathic human hearts. Mol Cell Biochem 1996; 155: 13-21.
5. Cleutjens JP, Blankesteijn WM, Daemen MJ, Smits JF. The infarcted myocardium: simply dead tissue, or a lively target for therapeutic interventions. Cardiovasc Res 1999; 44: 232-241.
6. Drobnik J, Szczepanowska A, Dabrowski R. Temporary augmentation of glycosaminoglycans in the heart after the left coronary artery ligation. Pathophysiology 2004; 11: 35-39.
7. Squires CE, Escobar GP, Payne JF, et al. Altered fibroblast function following myocardial infarction. J Mol Cell Cardiol 2005; 39: 699-707.
8. Drobnik J, Slotwinska D, Olczak S, et al. Pharmacological doses of melatonin reduce the glycosaminoglycan level within the infarcted heart scar. J Physiol Pharmacol 2011; 62: 29-35.
9. Drobnik J, Karbownik-Lewinska M, Szczepanowska A, et al. Regulatory influence of melatonin on collagen accumulation in the infarcted heart scar. J Pineal Res 2008; 45: 285-290.
10. Drobnik J, Dabrowski R. Melatonin suppresses the pinealectomy-induced elevation of collagen content in the wound. Cytobios 1996; 85: 51-58.
11. Drobnik J, Owczarek K, Piera L, et al. Melatonin-induced augmentation of collagen deposition in cultures of fibroblasts and myofibroblasts is blocked by luzindole-a melatonin membrane receptors inhibitor. Pharmacol Rep 2013; 65: 642-649.
12. Eyden B. The myofibroblast: an assessment of controversial issues and definition useful in diagnosis and research. Ultrastruct Pathol 2001; 25: 39-50.
13. Woessner JF. The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch Biochem Biophys 1967; 93: 440-445.
14. Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and determination of sulphated glycosaminoglycans by use dimethylmethylene blue. Biochem Biophys Acta 1986; 883: 173-177.
15. Srinivasan V, Pandi-Perumal SR, Trakht I, et al. Pathophysiology of depression: role of sleep and melatonergic system. Psych Res 2009; 165: 201-214.
16. Szczepanik M. Melatonin and its influence on immune system. J Physiol Pharmacol 2007; 58(Suppl. 6): 115-124.
17. Juszczak M. Melatonin affects the oxytocin and prolactin responses to stress in male rats. J Physiol Pharmacol 1998; 48: 151-163.
18. Nakade O, Koyama H, Ariji H, Yajima A, Kaku T. Melatonin stimulates proliferation and type I collagen synthesis in human bone cells in vitro. J Pineal Res 1999; 27: 106-110.
19. Dubocovich ML, Delagrange P, Krause DN, Sugden D, Cardinali DP, Olcese J. International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. Pharmacol Rev 2010; 62: 343-380.
20. Benitez-King G, Huerto-Delgadillo L, Anton-Tay F. Binding of 3H-melatonin to calmodulin. Life Sci 1993; 53: 201-207.
21. Becker-Andre M, Wiesenberg I, Schaeren-Wiemers N, et al. Pineal gland hormone binds and activates an orphan of the nuclear receptor superfamily. J Biol Chem 1994, 269: 28531-28534.
22. Mink SN, Jacobs H, Gotes J, Kasian K, Cheng ZQ. Ethyl gallate, a scavenger of hydrogen peroxide inhibits lysozyme-induced hydrogen peroxide signaling in vitro, reverses hypotension in canine septic shock. J Appl Physiol 2011; 110: 359-374.
23. Maldonato MD, Siu AW, Sanchez-Hidalgo M, Acuna-Castroviejo D, Escames G. Melatonin and lipid uptake by murine fibroblasts: clinical implications. Neuro Endocrinol Lett 2006; 27: 601-608.
24. Choi SL, Dadakhujaev S, Ryu H, Im Kim T, Kim EK. Melatonin protects against oxidative stress in granular corneal dystrophy type 2 corneal fibroblasts by mechanisms that involve membrane melatonin receptors. J Pineal Res 2011; 51: 94-103.
25. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia MJ, Sanchez J, Marrero F, de Armas-Trujillo D. Decreased nocturnal melatonin levels during acute myocardial infarction. J Pineal Res 2002; 33: 248-252.
26. Dominguez-Rodriguez A, Abreu-Gonzalez P, Arroyo-Ucar E, Reiter RJ. Decreased level of melatonin in serum predicts left ventricular remodeling after acute myocardial infarction. J Pineal Res 2012; 53: 319-323.
27. Sallinen P, Manttari S, Leskinen H, et al. The effect of myocardial infarction on the synthesis, concentration and receptor expression of endogenous melatonin. J Pineal Res 2007; 42: 254-260.
28. Tous E, Ifkovits JL, Koomalsingh KJ, et al. Influence of injectable hyaluronic acid hydrogel degradation behavior on infarction-induced ventricular remodeling. Biomacromolecules 2011; 12: 4127-4135.
29. Fomovsky MG, Thomopoulos S, Holmes JW. Contribution of extracellular matrix to the mechanical properties of the heart. J Mol Cell Cardiol 2010; 48: 490-496.
30. Mukherjee D, Roy SG, Bandyopadhyay A, et al. Melatonin protects against isoproterenol-induced myocardial injury in the rat: antioxidative mechanisms. J Pineal Res 2010; 48: 251-262.
31. Albertini R, Passi A, Abuja PM, De Luca G. The effect of glycosaminoglycans and proteoglycans on lipid peroxidation. Int J Mol Med 2000; 6:129-136.
32. Mukherjee D, Ghosh AK, Bandyopadhyay A, et al. Melatonin protects against isoproterenol-induced alterations in cardiac mitochondrial energy-metabolizing enzymes, apoptotic proteins, and assists in complete recovery from myocardial injury in rats. J Pineal Res 2012; 53: 166-179.
33. Van den Borne SW, Isobe S, Verjans JW, et al. Molecular imaging of interstitial alterations in remodeling myocardium after myocardial infarction. J Am Coll Cardiol 2008; 52: 2017-2028.